Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	TUDOR	RNF17 TDRD7 TDRD3	5.19e-05	14	100	3	PF00567
Domain	Ser/Thr_kinase_AS	TLK2 MYLK CAMK1G NEK4 MAPK12 DSTYK PRKCA PRKCH IKBKB	1.27e-04	357	100	9	IPR008271
Domain	S_TKc	TLK2 MYLK CAMK1G NEK4 MAPK12 DSTYK PRKCA PRKCH IKBKB	1.32e-04	359	100	9	SM00220
Domain	PROTEIN_KINASE_ST	TLK2 MYLK CAMK1G NEK4 MAPK12 DSTYK PRKCA PRKCH IKBKB	1.41e-04	362	100	9	PS00108
Domain	Pkinase	TLK2 MYLK CAMK1G NEK4 MAPK12 DSTYK PRKCA PRKCH IKBKB	2.07e-04	381	100	9	PF00069
Domain	TUDOR	RNF17 TDRD7 TDRD3	2.44e-04	23	100	3	PS50304
Domain	-	ZNF142 ZNF155 ZNF549 ZNF407 ZNF225 ZNF181 ZNF117 ZNF41 ZNF425 ZFP1 ZNF333 ZNF292	2.73e-04	679	100	12	3.30.160.60
Domain	zf-C2H2	ZNF142 ZNF155 ZNF549 ZNF407 ZNF225 ZNF181 ZNF117 ZNF41 ZNF425 ZFP1 ZNF333 ZNF292	3.28e-04	693	100	12	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF142 ZNF155 ZNF549 ZNF407 ZNF225 ZNF181 ZNF117 ZNF41 ZNF425 ZFP1 ZNF333 ZNF292	3.32e-04	694	100	12	IPR013087
Domain	TUDOR	RNF17 TDRD7 TDRD3	3.97e-04	27	100	3	SM00333
Domain	Tudor	RNF17 TDRD7 TDRD3	5.44e-04	30	100	3	IPR002999
Domain	KRAB	ZNF155 ZNF549 ZNF225 ZNF181 ZNF41 ZNF425 ZFP1 ZNF333	6.78e-04	358	100	8	PS50805
Domain	KRAB	ZNF155 ZNF549 ZNF225 ZNF181 ZNF41 ZNF425 ZFP1 ZNF333	6.78e-04	358	100	8	PF01352
Domain	PROTEIN_KINASE_ATP	TLK2 MYLK CAMK1G NEK4 MAPK12 DSTYK PRKCA PRKCH IKBKB	7.97e-04	459	100	9	PS00107
Domain	KRAB	ZNF155 ZNF549 ZNF225 ZNF181 ZNF41 ZNF425 ZFP1 ZNF333	8.25e-04	369	100	8	SM00349
Domain	KRAB	ZNF155 ZNF549 ZNF225 ZNF181 ZNF41 ZNF425 ZFP1 ZNF333	8.39e-04	370	100	8	IPR001909
Domain	ZINC_FINGER_C2H2_2	ZNF142 ZNF155 ZNF549 ZNF407 ZNF225 ZNF181 ZNF117 ZNF41 ZNF425 ZFP1 ZNF333 ZNF292	8.83e-04	775	100	12	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF142 ZNF155 ZNF549 ZNF407 ZNF225 ZNF181 ZNF117 ZNF41 ZNF425 ZFP1 ZNF333 ZNF292	9.03e-04	777	100	12	PS00028
Domain	Protein_kinase_ATP_BS	TLK2 MYLK CAMK1G NEK4 MAPK12 DSTYK PRKCA PRKCH	9.80e-04	379	100	8	IPR017441
Domain	Znf_C2H2-like	ZNF142 ZNF155 ZNF549 ZNF407 ZNF225 ZNF181 ZNF117 ZNF41 ZNF425 ZFP1 ZNF333 ZNF292	1.11e-03	796	100	12	IPR015880
Domain	Znf_C2H2	ZNF142 ZNF155 ZNF549 ZNF407 ZNF225 ZNF181 ZNF117 ZNF41 ZNF425 ZFP1 ZNF333 ZNF292	1.22e-03	805	100	12	IPR007087
Domain	Prot_kinase_dom	TLK2 MYLK CAMK1G NEK4 MAPK12 DSTYK PRKCA PRKCH IKBKB	1.24e-03	489	100	9	IPR000719
Domain	ZnF_C2H2	ZNF142 ZNF155 ZNF549 ZNF407 ZNF225 ZNF181 ZNF117 ZNF41 ZNF425 ZFP1 ZNF333 ZNF292	1.26e-03	808	100	12	SM00355
Domain	PROTEIN_KINASE_DOM	TLK2 MYLK CAMK1G NEK4 MAPK12 DSTYK PRKCA PRKCH IKBKB	1.31e-03	493	100	9	PS50011
Domain	SET	SMYD1 KMT5A EZH2	1.37e-03	41	100	3	PF00856
Domain	zf-C2H2_6	ZNF155 ZNF549 ZNF225 ZNF181 ZNF117 ZNF425 ZNF333	1.50e-03	314	100	7	PF13912
Domain	ZnF_BED	ZNF181 ZNF333	1.51e-03	11	100	2	SM00614
Domain	Keratin_I	KRT16 KRT27 KRT28	1.68e-03	44	100	3	IPR002957
Domain	Znf_BED	ZNF181 ZNF333	1.81e-03	12	100	2	IPR003656
Domain	SET	SMYD1 KMT5A EZH2	1.91e-03	46	100	3	SM00317
Domain	SET_dom	SMYD1 KMT5A EZH2	2.43e-03	50	100	3	IPR001214
Domain	SET	SMYD1 KMT5A EZH2	2.43e-03	50	100	3	PS50280
Domain	Dynein_heavy_chain_D4_dom	DNAH2 DNAH1	2.48e-03	14	100	2	IPR024317
Domain	Dynein_HC_stalk	DNAH2 DNAH1	2.48e-03	14	100	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH2 DNAH1	2.48e-03	14	100	2	IPR013602
Domain	DHC_N2	DNAH2 DNAH1	2.48e-03	14	100	2	PF08393
Domain	MT	DNAH2 DNAH1	2.48e-03	14	100	2	PF12777
Domain	AAA_8	DNAH2 DNAH1	2.48e-03	14	100	2	PF12780
Domain	ATPase_dyneun-rel_AAA	DNAH2 DNAH1	2.48e-03	14	100	2	IPR011704
Domain	zf-H2C2_2	ZFP1 ZNF333	2.48e-03	14	100	2	PF13465
Domain	AAA_5	DNAH2 DNAH1	2.48e-03	14	100	2	PF07728
Domain	Kinase-like_dom	TLK2 MYLK CAMK1G NEK4 MAPK12 DSTYK PRKCA PRKCH IKBKB	2.50e-03	542	100	9	IPR011009
Domain	DHC_fam	DNAH2 DNAH1	2.85e-03	15	100	2	IPR026983
Domain	Dynein_heavy_dom	DNAH2 DNAH1	2.85e-03	15	100	2	IPR004273
Domain	Dynein_heavy	DNAH2 DNAH1	2.85e-03	15	100	2	PF03028
Pathway	REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS	KRAS SPTBN1 MYO18A GOLGB1	2.42e-06	19	73	4	M41732
Pathway	REACTOME_FLT3_SIGNALING_IN_DISEASE	KRAS SPTBN1 MYO18A GOLGB1	1.23e-05	28	73	4	M41724
Pathway	WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3	KRAS MAPK12 PRKCA PRKCH IKBKB	4.22e-05	75	73	5	M39568
Pathway	BIOCARTA_LIS1_PATHWAY	RELN DNAH2 DNAH1	1.22e-04	19	73	3	M22005
Pubmed	Down-Regulation of Inpp5e Associated With Abnormal Ciliogenesis During Embryonic Neurodevelopment Under Inositol Deficiency.	KRAS PKHD1 PRKCA	8.75e-07	7	103	3	34093381
Pubmed	A French family with Charcot-Marie-Tooth disease related to simultaneous heterozygous MFN2 and GDAP1 mutations.	GDAP1 MFN2	8.69e-06	2	103	2	22546700
Pubmed	Phosphorylation of smooth muscle myosin light chain kinase by protein kinase C. Comparative study of the phosphorylated sites.	MYLK PRKCA	8.69e-06	2	103	2	3160694
Pubmed	Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma.	KRAS EZH2	8.69e-06	2	103	2	28539837
Pubmed	Mitofusin-2 regulates mitochondrial and endoplasmic reticulum morphology and tethering: the role of Ras.	KRAS MFN2	8.69e-06	2	103	2	19269351
Pubmed	IKKβ Kinase Promotes Stemness, Migration, and Invasion in KRAS-Driven Lung Adenocarcinoma Cells.	KRAS IKBKB	8.69e-06	2	103	2	32823550
Pubmed	Sphincter of Oddi Dysfunction Induces Gallstone by Inhibiting the Expression of ABCB11 via PKC-α.	ABCB11 PRKCA	8.69e-06	2	103	2	38158489
Pubmed	Phosphorylation of the cytosolic domain of peptidylglycine alpha-amidating monooxygenase.	PAM PRKCA	8.69e-06	2	103	2	8530412
Pubmed	Homozygous Mutations in GDAP1 and MFN2 Genes Resulted in Autosomal Recessive Forms of Charcot-Marie-Tooth Disease in Consanguineous Pakistani Families.	GDAP1 MFN2	8.69e-06	2	103	2	37797217
Pubmed	MTCH2 cooperates with MFN2 and lysophosphatidic acid synthesis to sustain mitochondrial fusion.	MFN2 MTCH2	8.69e-06	2	103	2	38177900
Pubmed	A human MAP kinase interactome.	TOM1L2 ZNF142 SETX CCDC186 SPTBN1 MYO18A PRKCH GOLGB1 WDR44	1.48e-05	486	103	9	20936779
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	KRAS NUP107 CCDC186 KMT5A SPTBN1 DNAH2 MYO18A RNF17 MTCH2 RPL8 GOLGB1	1.51e-05	754	103	11	35906200
Pubmed	Charting the molecular links between driver and susceptibility genes in colorectal cancer.	KRAS TDRD7 MAPK12 TSTD2 HSD17B3	1.73e-05	107	103	5	24412244
Pubmed	Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.	CCDC186 MYO18A PTPRD FANCI ABCB11 MTCH2 GOLGB1	2.33e-05	285	103	7	32838362
Pubmed	Cav-1 regulates the bile salt export pump on the canalicular membrane of hepatocytes by PKCα-associated signalling under cholesterol stimulation.	ABCB11 PRKCA	2.60e-05	3	103	2	38164042
Pubmed	Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network.	KRAS EZH2	2.60e-05	3	103	2	26457648
Pubmed	USP11 controls R-loops by regulating senataxin proteostasis.	SETX USP11	2.60e-05	3	103	2	34526504
Pubmed	Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities.	KRAS EZH2	2.60e-05	3	103	2	30487290
Pubmed	Polycomb deficiency drives a FOXP2-high aggressive state targetable by epigenetic inhibitors.	KRAS EZH2	2.60e-05	3	103	2	36670102
Pubmed	Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation.	KRAS IKBKB	2.60e-05	3	103	2	20129250
Pubmed	Gas6/MerTK signaling is negatively regulated by NF-κB and supports lung carcinogenesis.	KRAS IKBKB	2.60e-05	3	103	2	31903163
Pubmed	Ezh2 is involved in radial neuronal migration through regulating Reelin expression in cerebral cortex.	RELN EZH2	2.60e-05	3	103	2	26499080
Pubmed	KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma.	KRAS IKBKB	2.60e-05	3	103	2	22264792
Pubmed	Collaboration of Kras and androgen receptor signaling stimulates EZH2 expression and tumor-propagating cells in prostate cancer.	KRAS EZH2	2.60e-05	3	103	2	22805308
Pubmed	Disruption of the Golgi protein Otg1 gene causes defective hormone secretion and aberrant glucose homeostasis in mice.	CCDC186 GOLGB1	2.60e-05	3	103	2	27293546
Pubmed	RAS oncogenic signal upregulates EZH2 in pancreatic cancer.	KRAS EZH2	2.60e-05	3	103	2	22222375
Pubmed	Taking the next step forward - Diagnosing inherited infantile cholestatic disorders with next generation sequencing.	PKHD1 ABCB11	2.60e-05	3	103	2	25771912
Pubmed	Quantitative proteome analysis of detergent-resistant membranes identifies the differential regulation of protein kinase C isoforms in apoptotic T cells.	PRKCA PRKCH	2.60e-05	3	103	2	20486122
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TLK2 KRAS DOCK11 SPTBN1 NOSIP TDRD3 PTPRD MFN2 PRKCA CDK5RAP2 CEP170B GOLGB1	2.88e-05	963	103	12	28671696
Pubmed	Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model.	KRAS IKBKB	5.19e-05	4	103	2	22327365
Pubmed	Protein kinase Cα suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGFβ signaling axis.	KRAS PRKCA	5.19e-05	4	103	2	23604119
Pubmed	EZH2 couples pancreatic regeneration to neoplastic progression.	KRAS EZH2	5.19e-05	4	103	2	22391448
Pubmed	Targeting SOD1 reduces experimental non–small-cell lung cancer.	KRAS IKBKB	5.19e-05	4	103	2	24292713
Pubmed	Mutations in the helix termination motif of mouse type I IRS keratin genes impair the assembly of keratin intermediate filament.	KRT27 KRT28	5.19e-05	4	103	2	17920809
Pubmed	Neutrophil-Derived IL-1β Impairs the Efficacy of NF-κB Inhibitors against Lung Cancer.	KRAS IKBKB	5.19e-05	4	103	2	27320908
Pubmed	Inhibition of TRPC6 by protein kinase C isoforms in cultured human podocytes.	PRKCA PRKCH	5.19e-05	4	103	2	26404773
Pubmed	Expression of protein kinase C isoforms and interleukin-1beta in myofibrillar myopathy.	PRKCA PRKCH	5.19e-05	4	103	2	15159477
Pubmed	RAS signalling through PI3-Kinase controls cell migration via modulation of Reelin expression.	KRAS RELN	5.19e-05	4	103	2	27071537
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	TLK2 GLT6D1 BIRC8 MYLK DNAH2 CAMK1G MAPK12 PRKCA PRKCH PPP1R27	6.37e-05	730	103	10	34857952
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	SETX NUP107 USP11 NOSIP TDRD3 MTR MTREX CEP170B GOLGB1	6.51e-05	588	103	9	38580884
Pubmed	Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer.	KRAS EZH2	8.64e-05	5	103	2	26766588
Pubmed	Novel (n)PKC kinases phosphorylate Nef for increased HIV transcription, replication and perinuclear targeting.	PRKCA PRKCH	8.64e-05	5	103	2	17904606
Pubmed	IκB Kinase α Is Required for Development and Progression of KRAS-Mutant Lung Adenocarcinoma.	KRAS IKBKB	8.64e-05	5	103	2	29588349
Pubmed	Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice.	KRAS IKBKB	8.64e-05	5	103	2	22056382
Pubmed	Stage- and subunit-specific functions of polycomb repressive complex 2 in bladder urothelial formation and regeneration.	KRT16 MYLK EZH2	8.72e-05	29	103	3	28049658
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	RELN SETX KRT16 SPTBN1 MYO18A RCN2 AGPS DHX30 PAN2 MTCH2 RPL8 ZNF292	8.78e-05	1082	103	12	38697112
Pubmed	The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.	SPTBN1 TNKS2 IKBKB	9.66e-05	30	103	3	30480076
Pubmed	Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia.	USP11 SPTBN1 MYO18A MTREX MTCH2	9.85e-05	154	103	5	36490346
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	NUP107 CCDC186 TDRD3 CDK5RAP2 CEP170B CCDC93	1.06e-04	251	103	6	29778605
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SETX KRT16 NUP107 CCDC186 AGPS FRMD6 CDK5RAP2 PRKCH RPL8 GOLGB1	1.06e-04	777	103	10	35844135
Pubmed	TNF inhibits Notch-1 in skeletal muscle cells by Ezh2 and DNA methylation mediated repression: implications in duchenne muscular dystrophy.	EZH2 IKBKB	1.29e-04	6	103	2	20814569
Pubmed	Protein kinase C isoform expression and activity in the mouse heart.	PRKCA PRKCH	1.29e-04	6	103	2	11668067
Pubmed	AKAP-Lbc nucleates a protein kinase D activation scaffold.	PRKCA PRKCH	1.29e-04	6	103	2	15383279
Pubmed	Translocation of diacylglycerol kinase theta from cytosol to plasma membrane in response to activation of G protein-coupled receptors and protein kinase C.	PRKCA PRKCH	1.29e-04	6	103	2	15632189
Pubmed	Different regulation of PKC isoenzymes and MAPK by PSK and IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line.	MAPK12 PRKCA	1.29e-04	6	103	2	12536241
Pubmed	Transposon mutagenesis identifies genes and evolutionary forces driving gastrointestinal tract tumor progression.	KRAS ZNF292	1.29e-04	6	103	2	25559195
Pubmed	Diacylglycerol kinase θ counteracts protein kinase C-mediated inactivation of the EGF receptor.	PRKCA PRKCH	1.29e-04	6	103	2	22732145
Pubmed	Platelet P-selectin expression: requirement for protein kinase C, but not protein tyrosine kinase or phosphoinositide 3-kinase.	PRKCA PRKCH	1.29e-04	6	103	2	12783114
Pubmed	Potential genetic variants in schizophrenia: a Bayesian analysis.	RELN SYN3	1.29e-04	6	103	2	17366345
Pubmed	Role of histone H3 lysine 27 methylation in Polycomb-group silencing.	KMT5A EZH2	1.29e-04	6	103	2	12351676
Pubmed	Isolation of several human axonemal dynein heavy chain genes: genomic structure of the catalytic site, phylogenetic analysis and chromosomal assignment.	DNAH2 DNAH1	1.81e-04	7	103	2	9256245
Pubmed	Modulation of apoptotic response by LAR family phosphatases-cIAP1 signaling during urinary tract morphogenesis.	BIRC8 PTPRD	1.81e-04	7	103	2	29073098
Pubmed	Arf4 is required for Mammalian development but dispensable for ciliary assembly.	PKHD1 GOLGB1	1.81e-04	7	103	2	24586199
Pubmed	Toll-like receptors 2, 4, and 9 modulate promoting effect of COPD-like airway inflammation on K-ras-driven lung cancer through activation of the MyD88/NF-ĸB pathway in the airway epithelium.	KRAS IKBKB	1.81e-04	7	103	2	37283745
Pubmed	The Protein-tyrosine-phosphatase SHP2 is phosphorylated on serine residues 576 and 591 by protein kinase C isoforms alpha, beta 1, beta 2, and eta.	PRKCA PRKCH	1.81e-04	7	103	2	11781100
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	ZNF142 NUP107 KMT5A SPTBN1 ZNF407 AGPS TIMM21 FANCI MFN2 MTCH2 RPL8 GOLGB1	2.35e-04	1203	103	12	29180619
Pubmed	SMN and symmetric arginine dimethylation of RNA polymerase II C-terminal domain control termination.	SETX TDRD3	2.40e-04	8	103	2	26700805
Pubmed	Distribution of the extended family of protein kinase C isoenzymes in fetal organs of mice: an immunohistochemical study.	PRKCA PRKCH	2.40e-04	8	103	2	7606770
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SETX DOCK11 SPTBN1 KIAA1191 NEK4 FRMD6 DSTYK MTREX CEP170B GOLGB1	2.43e-04	861	103	10	36931259
Pubmed	SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.	SETX KRT16 KRT27 SPTBN1 RCN2 DHX30 TIMM21 RPL8	2.62e-04	558	103	8	27591049
Pubmed	An Interaction Network of the Human SEPT9 Established by Quantitative Mass Spectrometry.	MYLK FANCI PRKCA	2.86e-04	43	103	3	30975701
Pubmed	Regulation of HIV-1 gag protein subcellular targeting by protein kinase C.	PRKCA PRKCH	3.08e-04	9	103	2	7876252
Pubmed	Phosphorylation of HIV-1 gag proteins by protein kinase C.	PRKCA PRKCH	3.08e-04	9	103	2	8473314
Pubmed	Phosphorylation of the cytoplasmic domain of the integrin CD18 chain by protein kinase C isoforms in leukocytes.	PRKCA PRKCH	3.08e-04	9	103	2	11700305
Pubmed	aPKC-mediated phosphorylation regulates asymmetric membrane localization of the cell fate determinant Numb.	PRKCA PRKCH	3.08e-04	9	103	2	17203073
Pubmed	Inhibition of protein kinase C by a synthetic peptide corresponding to cytoplasmic domain residues 828-848 of the human immunodeficiency virus type 1 envelope glycoprotein.	PRKCA PRKCH	3.08e-04	9	103	2	7850771
Pubmed	Human immunodeficiency virus-1 recombinant gp120 induces changes in protein kinase C isozymes--a preliminary report.	PRKCA PRKCH	3.08e-04	9	103	2	8206685
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	USP11 MATN3 SPTBN1 EZH2 TUFT1 TRIM45 NSMF PTPRD FANCI CDK5RAP2 IKBKB LRRC23	3.13e-04	1242	103	12	30973865
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	NUP107 DOCK11 USP11 AGPS DHX30 MTREX RPL8	3.45e-04	440	103	7	34244565
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	SETX NUP107 SPTBN1 RNF17 EIF2D FANCI MTREX GOLGB1	3.46e-04	582	103	8	20467437
Pubmed	Analyses of shared genetic factors between asthma and obesity in children.	PTPRD PRKCA MTCH2	3.72e-04	47	103	3	20816195
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TOM1L2 TLK2 BIRC8 AHI1 SETX SPTBN1 TTC14 PAN2 CDK5RAP2 TSTD2 GOLGB1	3.74e-04	1084	103	11	11544199
Pubmed	The phorbol ester TPA strongly inhibits HIV-1-induced syncytia formation but enhances virus production: possible involvement of protein kinase C pathway.	PRKCA PRKCH	3.85e-04	10	103	2	1970444
Pubmed	Dynein and kinesin regulate stress-granule and P-body dynamics.	DNAH2 DNAH1	3.85e-04	10	103	2	19825938
Pubmed	Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway.	PRKCA PRKCH	3.85e-04	10	103	2	11884598
Pubmed	Migration, early axonogenesis, and Reelin-dependent layer-forming behavior of early/posterior-born Purkinje cells in the developing mouse lateral cerebellum.	RELN GOLGB1	3.85e-04	10	103	2	20809939
Pubmed	Human immunodeficiency virus induces phosphorylation of its cell surface receptor.	PRKCA PRKCH	3.85e-04	10	103	2	3259291
Pubmed	Effect of serine and tyrosine phosphorylation on retroviral proteinase substrates.	PRKCA PRKCH	3.85e-04	10	103	2	10491200
Pubmed	Inhibition of protein kinase C and anti-CD3-induced Ca2+ influx in Jurkat T cells by a synthetic peptide with sequence identity to HIV-1 gp41.	PRKCA PRKCH	3.85e-04	10	103	2	2139676
Pubmed	ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress.	BIRC8 IKBKB	3.85e-04	10	103	2	20932476
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	TOM1L2 COL6A1 MYO18A AGPS FANCI CDK5RAP2 MTREX GOLGB1 CCDC93	4.13e-04	754	103	9	33060197
Pubmed	Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects.	COL6A1 RELN MATN3 PRKCA PRKCH	4.15e-04	210	103	5	16537572
Pubmed	Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin.	SPTBN1 ZNF333	4.69e-04	11	103	2	17607528
Pubmed	Specific isoforms of protein kinase C are essential for prevention of folate-resistant neural tube defects by inositol.	PRKCA PRKCH	4.69e-04	11	103	2	14613966
Pubmed	IL-16- and other CD4 ligand-induced migration is dependent upon protein kinase C.	PRKCA PRKCH	4.69e-04	11	103	2	8599832
Pubmed	Trans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase C.	PRKCA PRKCH	4.69e-04	11	103	2	2182321
Pubmed	Phosphorylation of tau is regulated by PKN.	MAPK12 PRKCA	4.69e-04	11	103	2	11104762
Pubmed	Bimodal regulation of the PRC2 complex by USP7 underlies tumorigenesis.	SPTBN1 EZH2	4.69e-04	11	103	2	33849069
Pubmed	A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype.	KRAS EZH2	4.69e-04	11	103	2	24623306
Pubmed	IL-1 Transcriptional Responses to Lipopolysaccharides Are Regulated by a Complex of RNA Binding Proteins.	EZH2 NSMF	4.69e-04	11	103	2	31953354
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF142 ZNF155 ZNF549 ZNF407 ZNF225 ZNF181 ZNF117 ZNF41 ZNF425 ZFP1 ZNF333 ZNF292	9.63e-06	718	66	12	28
GeneFamily	Keratins, type I	KRT16 KRT27 KRT28	1.43e-04	28	66	3	608
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	SMYD1 KMT5A EZH2	2.56e-04	34	66	3	487
GeneFamily	Tudor domain containing	RNF17 TDRD7 TDRD3	3.30e-04	37	66	3	780
GeneFamily	C2 domain containing protein kinases	PRKCA PRKCH	5.80e-04	10	66	2	835
GeneFamily	Dyneins, axonemal	DNAH2 DNAH1	1.72e-03	17	66	2	536
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	TLK2 KRAS ZNF142 AHI1 KMT5A ZNF407 FEM1C PAN2 MFN2 CDK5RAP2 TNKS2 GOLGB1 ZNF292	4.92e-06	595	101	13	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	TLK2 KRAS ZNF142 KMT5A ZNF407 FEM1C EZH2 NEK4 CDK5RAP2 TNKS2 GOLGB1 ZNF292	1.52e-05	564	101	12	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	TLK2 KRAS ZNF142 DNAH2 ZNF407 CCDC66 MFN2 CDK5RAP2 MTREX TNKS2 GOLGB1 ZNF292	4.43e-05	629	101	12	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_3\|COVID-19_Convalescent / Disease condition and Cell class	TOM1L2 KRAS USP11 KMT5A KIAA1191 TDRD3 EIF2D	2.91e-07	189	103	7	732e8dcffcb634ca2968f9170c9c4b31dd5d4206
ToppCell	356C-Lymphocytic-ILC-ILC-2\|ILC / Donor, Lineage, Cell class and subclass (all cells)	CRACR2A KMT5A FRMD6 ZFP1 PRKCA ZNF333	3.01e-06	172	103	6	4977e1f4deae781750e27a8054deccd336cfb74a
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 ZNF155 CAMK1G FEM1C TRIM45 DSTYK	3.67e-06	178	103	6	c87945146b2734141f07b39d268e0d8086ee0364
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN DNAH1 PTPRD XIRP2 OTOGL PKHD1	4.44e-06	184	103	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN DNAH1 PTPRD XIRP2 OTOGL PKHD1	4.44e-06	184	103	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN DNAH1 PTPRD XIRP2 OTOGL PKHD1	4.44e-06	184	103	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SPTBN1 TTC14 NOSIP LINS1 PRKCA PRKCH	5.17e-06	189	103	6	e9df7ecd36bee1fedce23bb188c68a94fa60462c
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	COL6A1 MYLK USP11 CAMK1G CPED1 PTPRD	5.50e-06	191	103	6	3379d145d34f89150f7b06d1340022cfc6b4a6ce
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NOSIP LINS1 CCDC66 MTR PRKCA PRKCH	5.50e-06	191	103	6	d9a6f61fcda4f5352488f7f55cb9b57aeacc717f
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	USP11 NOSIP CCDC66 MTR PRKCA PRKCH	5.50e-06	191	103	6	696921a4f160b6b55698652488ed781e855e5e51
ToppCell	(1)_T_cells-(1)_T_CD4_naive\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	SPTBN1 TTC14 NOSIP LINS1 CCDC66 PRKCA	6.19e-06	195	103	6	d3fa551bc6f5ee5890af1040415e61ecd5d46201
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 MYLK CPED1 PTPRD PAM CHRDL1	6.56e-06	197	103	6	cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TLK2 TTC14 ZNF407 PRKCH GOLGB1 ZNF292	6.95e-06	199	103	6	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	AHI1 MYLK RCN2 CPED1 FRMD6 CHRDL1	7.15e-06	200	103	6	c5e051f1aac8dda376c342a9932785a23450e073
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-T_cells-SELL+_CD8_T\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SUSD4 TSGA10 NOSIP CCDC65 SEC14L5	4.58e-05	169	103	5	cc1b60eb50a274ffd72c67082c19e43af775e949
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SYN3 ZNF407 CAMK1G TDRD7 PRKCH	4.98e-05	172	103	5	3b9be685fcd1634498a603b692f5ac6ddd0de176
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-GC_B_(I)\|bone_marrow / Manually curated celltypes from each tissue	GDAP1 EZH2 ZNF117 FANCI LRRC23	5.12e-05	173	103	5	67f0f0bf88eab69987b71d96b864ed2b14975adb
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHI1 DOCK11 CCDC186 PTPRD PAM	5.71e-05	177	103	5	1dc69c661e70e7e22bd9d7cf953eb638da9fd43c
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHI1 DOCK11 CCDC186 PTPRD PAM	5.71e-05	177	103	5	426a9845df7fd13b02e744532c336c60bc4d4a22
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A1 MYLK MATN3 PTPRD OTOGL	6.02e-05	179	103	5	dc6cd46fa652b296ddbc41855f6377946d0a4cdc
ToppCell	E18.5-samps-Mesenchymal-Matrix_fibroblast\|E18.5-samps / Age Group, Lineage, Cell class and subclass	COL6A1 MYLK CPED1 PTPRD C1orf216	6.51e-05	182	103	5	ceb37c214662a48efb56ab0d015977c6fab478b0
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NOSIP LINS1 CCDC66 MTR PRKCA	6.86e-05	184	103	5	5350b58aa9979631228835d11eb45ddf81d08bff
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH2 TSGA10 DNAH1 FRMD6 LRRC23	7.04e-05	185	103	5	05bc89a566b0db90ae06506e067190a4739a0974
ToppCell	metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	GDAP1 EZH2 CPED1 CHRDL1 WDR44	7.22e-05	186	103	5	6259f0f2d5bc863782d09a901d6be2f387d1f074
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MATN3 CAMK1G CPED1 CHRDL1 PRKCA	7.59e-05	188	103	5	32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081
ToppCell	COVID-19_Convalescent-Classical_Monocyte-cMono_3\|Classical_Monocyte / Disease condition and Cell class	TOM1L2 USP11 KIAA1191 TDRD3 EIF2D	7.78e-05	189	103	5	8b6f92ccfffc743c07201bc971b3dc1a6fa14ccc
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	COL6A1 MYLK CAMK1G CPED1 PTPRD	7.78e-05	189	103	5	dc5164591dea45b420798b94dda211be03daa70c
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	COL6A1 MYLK CAMK1G CPED1 PTPRD	7.98e-05	190	103	5	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC186 KMT5A SPTBN1 KIAA1191 GOLGB1	8.18e-05	191	103	5	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	COL6A1 MYLK CPED1 PTPRD MTR	8.18e-05	191	103	5	e7c605b56934d1383237c1f946dbccef25d91368
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC186 KMT5A SPTBN1 KIAA1191 GOLGB1	8.18e-05	191	103	5	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL6A1 MYLK CAMK1G CPED1 PTPRD	8.38e-05	192	103	5	0afb9dbe468e0be442c326e11c5fc0f699b32f23
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 MYLK CAMK1G CPED1 PTPRD	8.59e-05	193	103	5	8d05805295c5d3aa93aeb38be5fbefa81e1be1f0
ToppCell	human_hepatoblastoma-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	SYN3 NUP107 EZH2 FANCI PRKCA	8.59e-05	193	103	5	4b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL6A1 MYLK CAMK1G CPED1 PTPRD	8.80e-05	194	103	5	f15e81ff12525523c62d13105cf264ea72205e2e
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL6A1 MYLK CAMK1G CPED1 PTPRD	8.80e-05	194	103	5	f2f7b9aad7588c8020a4850ff9333e1db8eafac7
ToppCell	PND07-28-samps-Mesenchymal\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	COL6A1 MYLK CPED1 PTPRD PAM	8.80e-05	194	103	5	68bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SPTBN1 NOSIP MTR PRKCA PRKCH	8.80e-05	194	103	5	a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2
ToppCell	PND01-Mesenchymal-Mesenchymal_structural\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 MYLK EZH2 CPED1 PTPRD	9.01e-05	195	103	5	6bb6349d6ec8da094fe1c7c590021989337aeb0b
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 MYLK CAMK1G CPED1 PTPRD	9.01e-05	195	103	5	598b69032a8441a23749b27863d80f7a1fc82a96
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 MYLK EZH2 CPED1 PTPRD	9.01e-05	195	103	5	a3b468125e48f072255cede7645f6692298ecf54
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	AHI1 USP11 CCDC66 PRKCH ZNF292	9.01e-05	195	103	5	ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 MYLK CAMK1G CPED1 PTPRD	9.01e-05	195	103	5	8aa753934debffe5ae4b5eecb6b50c46d17cc3ec
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL6A1 MYLK CAMK1G CPED1 PTPRD	9.01e-05	195	103	5	b072fdc2131173f562e55dd78226eaf2c57d3690
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 AHI1 CCDC186 CPED1 PTPRD	9.01e-05	195	103	5	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	facs-Thymus-Thymus_Epithelium\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 MYLK CPED1 PTPRD PAM	9.23e-05	196	103	5	6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCell	facs-Thymus-Thymus_Epithelium-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 MYLK CPED1 PTPRD PAM	9.23e-05	196	103	5	c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 MYLK CAMK1G CPED1 PTPRD	9.23e-05	196	103	5	617103f4a09e009fe96c28eb5e40505a4fd6dcf4
ToppCell	PND28-Mesenchymal\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 MYLK SYN3 CPED1 PTPRD	9.23e-05	196	103	5	119265efd2219f328d8152dbee52af8327aec89c
ToppCell	PND10-Mesenchymal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 MYLK CPED1 PTPRD PAM	9.23e-05	196	103	5	ace167a40adb7022b365be3c2b1cbd4ba963739a
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 MYLK CAMK1G CPED1 PTPRD	9.23e-05	196	103	5	db64ab27374f82553ee577aec056141170f3656f
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 MYLK EZH2 CPED1 PTPRD	9.46e-05	197	103	5	06a0d7062dadda656decaf77dcef9a10b5f2698d
ToppCell	droplet-Trachea-nan-3m-Mesenchymal-chondrocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT16 KMT5A MATN3 PAM PRKCA	9.46e-05	197	103	5	8786125b669d5d0b15e12df0ade6b319f09f7333
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	COL6A1 SPTBN1 NOSIP LINS1 PRKCA	9.46e-05	197	103	5	836dd8110d5689f944ad1d301def38c32278b5b5
ToppCell	5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RCN2 ZNF407 PTPRD ZNF425 CDK5RAP2	9.46e-05	197	103	5	789c97ca9d1e28df3353140046047f11fbccc1d0
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	AHI1 DHX30 CDK5RAP2 GOLGB1 ZNF292	9.46e-05	197	103	5	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 MYLK EZH2 CPED1 PTPRD	9.46e-05	197	103	5	d35c7a36135b5ed6a7bf2f934849678eba2a0177
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KRT16 KMT5A MATN3 PAM PRKCA	9.69e-05	198	103	5	3575620db5aeaeb0bdcd7a8ff65c43abd3fa13e4
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 MATN3 RCN2 PAM CHRDL1	9.92e-05	199	103	5	edd5300da1a3b758210ff8f949e9d1988b8bc7e2
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 MYLK CAMK1G CPED1 PTPRD	9.92e-05	199	103	5	2cec0e370ee9bb3c88a7acb5519e9ea8ddb399bc
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A1 MYLK CPED1 FRMD6 CHRDL1	9.92e-05	199	103	5	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A1 MYLK CAMK1G CPED1 PTPRD	9.92e-05	199	103	5	9e87b64e16d595701c3beb07aa835afe3330bd10
ToppCell	Biopsy_Other_PF-Mesenchymal-Myofibroblasts\|Biopsy_Other_PF / Sample group, Lineage and Cell type	COL6A1 MYLK PTPRD FRMD6 CHRDL1	1.02e-04	200	103	5	e504570fd7eec1524c401b1cfa9d10822d80d994
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	KRT16 DNAH2 DNAH1 CCDC65 LRRC23	1.02e-04	200	103	5	da12821e8a0657869ca0f75d351cce2d7605a505
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A1 MYLK CPED1 FRMD6 CHRDL1	1.02e-04	200	103	5	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	Control_saline-Mesenchymal_myocytic\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A1 MYLK CPED1 FRMD6 CHRDL1	1.02e-04	200	103	5	5ed4261157cd51109b314818133ac3a0d34ee5fa
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	AHI1 MYLK CPED1 FRMD6 CHRDL1	1.02e-04	200	103	5	8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A1 MYLK DOCK11 CPED1 OTOGL	1.02e-04	200	103	5	bc8949eb34482aca166c4602ff6ab876cb4c2c3c
ToppCell	LPS_IL1RA_TNF-Epithelial_airway\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	KRT16 DNAH2 DNAH1 CCDC65 LRRC23	1.02e-04	200	103	5	72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	COL6A1 MATN3 FANCI ABCB11	2.50e-04	132	103	4	893b7ec2a2d8a140cc98575d1beca1189f053e9a
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	COL6A1 MATN3 CPED1 FANCI	2.65e-04	134	103	4	b959899c89d3a0363a3cd2309155280e0fe5ba88
ToppCell	LPS-IL1RA-Endothelial-Epi-like-Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPTBN1 AGPS C1orf216 CCDC65	2.96e-04	138	103	4	5f8ac8f67e34a7cf560099208e6884102532391e
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast-MyoFB-1\|E18.5-samps / Age Group, Lineage, Cell class and subclass	MATN3 ABCB11 CCDC65 LRRC23	3.57e-04	145	103	4	ac41c6c02b7d78162b86222983688f54d04ac47d
ToppCell	343B-Myeloid-Macrophage-SPP1+_Macrophage_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ZNF142 KIAA1191 TUFT1 PRKCA	4.06e-04	150	103	4	744050a1b665c6989f37141348af3df7579a73c9
ToppCell	390C-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ZNF155 MYO18A DNAH1 MTR	4.27e-04	152	103	4	ebce79e106bf1d84241f8dd3496ff1771f9666be
ToppCell	390C-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ZNF155 MYO18A DNAH1 MTR	4.27e-04	152	103	4	4a749d1b6d35fd55a8c42d7bd04b6ff5b11ce781
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1\|Thalamus / BrainAtlas - Mouse McCarroll V32	COL6A1 MATN3 CPED1 FANCI	4.38e-04	153	103	4	e9c6fb5c41adb6595c66c3a917fe455348279e54
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1\|Thalamus / BrainAtlas - Mouse McCarroll V32	COL6A1 MATN3 CPED1 FANCI	4.38e-04	153	103	4	b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_TIP\|Thalamus / BrainAtlas - Mouse McCarroll V32	COL6A1 MATN3 CPED1 FANCI	4.38e-04	153	103	4	2513edfae62a44e51d3556675a096723194c966c
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GLT6D1 FCHO1 TRIM45 C1orf216	4.60e-04	155	103	4	51f6447945389649d99dcf7603b396195c631ead
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Mast_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GLT6D1 FCHO1 TRIM45 C1orf216	4.60e-04	155	103	4	23dc71cab28094ca0ac4d2baf4e24871ed107781
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN ZNF407 AGPS NEK4	4.82e-04	157	103	4	a426c54fd1545093d41426e9620862f71bd06f6b
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCHO1 NOSIP CCDC66 PRKCA	5.06e-04	159	103	4	b9d34b9ed8db798f5ea93c44b469cae499403cb8
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_TIP\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	COL6A1 MATN3 CPED1 ABCB11	5.06e-04	159	103	4	cb2470b288c13e454a2a80115b0d5613b3f718e6
ToppCell	VE-CD8-naive_CD4\|VE / Condition, Cell_class and T cell subcluster	ZNF155 CRACR2A ZNF425 CDK5RAP2	5.18e-04	160	103	4	255d2a150bfe19ee3d4d34533feb9c37ce73d225
ToppCell	10x5'-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4\|Lung / Manually curated celltypes from each tissue	BEND5 DNAH2 NOSIP PRKCA	5.43e-04	162	103	4	91cc14aec8d580cf97a1929bc1acb00fcbcdb57a
ToppCell	droplet-Marrow-nan-21m-Hematologic-erythroid_progenitor\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TOM1L2 SYN3 BEND5 MAPK12	5.43e-04	162	103	4	d0ffebf5adee8a3ac9b81a4b793184f54010489a
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KRT16 DNAH2 DNAH1 LRRC23	5.68e-04	164	103	4	e4d4c59aebe5cacd4ecdb907facd044dc82a831d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RELN SPTBN1 PRKCH IKBKB	5.81e-04	165	103	4	6a621b300442c52adfc15b61d3a6d3a3cb00099f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GLT6D1 SYN3 KRT27 PRKCH	5.95e-04	166	103	4	8e2faca6a2e76a625de04d6098aa6f98911945c6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SMYD1 EZH2 FANCI CDK5RAP2	6.08e-04	167	103	4	bc132b51dec4e8f1cd2b2cd89f83641976e09292
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-like-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF142 MATN3 FANCI TSTD2	6.22e-04	168	103	4	9e7b4b9b977e90e083f5164013e79df8bc2d492e
ToppCell	COVID-19-Heart-Neuronal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RELN CYP27C1 OTOGL PRKCA	6.22e-04	168	103	4	88c2c574f428c2502b5fe099bd73b0758f668ef6
ToppCell	TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	SUSD4 PTPRD DSTYK MTR	6.22e-04	168	103	4	c70bf73bb800e4722cedc35bbc17ea3113d1012d
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CRACR2A MAPK12 CDK5RAP2 PRKCH	6.36e-04	169	103	4	8caf7996796a2e2716e3855de855c903d6126bf2
ToppCell	facs-Lung-24m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	AGPS MFN2 TSTD2 CCDC93	6.36e-04	169	103	4	813472d429c0b12580b17b440e00a6d8beb7947f
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RNF17 DNAH1 OTOGL PKHD1	6.36e-04	169	103	4	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL6A1 MYLK PTPRD OTOGL	6.50e-04	170	103	4	49fc45d8a5c3ad89d1649fa46d7a285891379392
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL6A1 MYLK PTPRD OTOGL	6.50e-04	170	103	4	3174ea9cf93892a8b41de10fd4ff6f06bb41502d
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYLK CAMK1G CPED1 PTPRD	6.50e-04	170	103	4	e20568c8f3f17d94de78229617eb2f7e4c5af2bc
Disease	Adenocarcinoma of large intestine	KRAS NEK4 PRKCA PRKCH	2.67e-04	96	95	4	C1319315
Disease	Lymphoma	KRAS EZH2 MTR	2.93e-04	40	95	3	C0024299
Disease	Glaucoma	MYLK TDRD7	3.64e-04	9	95	2	C0017601
Disease	endometriosis (implicated_via_orthology)	KRAS EZH2	5.54e-04	11	95	2	DOID:289 (implicated_via_orthology)
Disease	Charcot-Marie-Tooth disease (is_implicated_in)	GDAP1 MFN2	6.63e-04	12	95	2	DOID:10595 (is_implicated_in)
Disease	Gastrointestinal Diseases	MYLK MTR	6.63e-04	12	95	2	C0017178
Disease	Functional Gastrointestinal Disorders	MYLK MTR	6.63e-04	12	95	2	C0559031
Disease	Cholera Infantum	MYLK MTR	6.63e-04	12	95	2	C1565321
Disease	Charcot-Marie-Tooth Disease	SETX GDAP1	6.63e-04	12	95	2	C0007959
Disease	velocity of sound measurement	SPTBN1 CPED1	7.82e-04	13	95	2	EFO_0005654
Disease	benign prostatic hyperplasia	SYN3 NUP107	9.10e-04	14	95	2	EFO_0000284
Disease	cerebellum cortex volume change measurement	SYN3 PTPRD	9.10e-04	14	95	2	EFO_0021497
Disease	Lymphoma, Follicular, Grade 2	EZH2 MTR	1.05e-03	15	95	2	C1956132
Disease	Lymphoma, Follicular, Grade 3	EZH2 MTR	1.05e-03	15	95	2	C1956131
Disease	Lymphoma, Follicular, Grade 1	EZH2 MTR	1.05e-03	15	95	2	C1956130
Disease	Lymphoma, Large-Cell, Follicular	EZH2 MTR	1.05e-03	15	95	2	C0079745
Disease	Lymphoma, Small Cleaved-Cell, Follicular	EZH2 MTR	1.05e-03	15	95	2	C0079765
Disease	Lymphoma, Mixed-Cell, Follicular	EZH2 MTR	1.05e-03	15	95	2	C0079758
Disease	dysmenorrheic pain measurement	KRAS GDAP1	1.20e-03	16	95	2	EFO_0007889
Disease	MYELODYSPLASTIC SYNDROME	KRAS EZH2 FANCI	1.33e-03	67	95	3	C3463824
Disease	protein C measurement	CYP27C1 FRMD6	1.35e-03	17	95	2	EFO_0004633
Disease	Charcot-Marie-Tooth disease type 2	GDAP1 MFN2	1.35e-03	17	95	2	cv:C0270914
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	TLK2 ZNF292	1.35e-03	17	95	2	DOID:0060307 (is_implicated_in)
Disease	nephrotic syndrome	AHI1 CCDC66 PTPRD	1.58e-03	71	95	3	EFO_0004255
Disease	Juvenile Myelomonocytic Leukemia	KRAS EZH2	1.69e-03	19	95	2	C0349639
Disease	exercise test	PTPRD PRKCA	1.88e-03	20	95	2	EFO_0004328
Disease	Lymphoma, Follicular	EZH2 MTR	1.88e-03	20	95	2	C0024301
Disease	Colorectal Carcinoma	KRAS ZNF155 PTPRD PKHD1 PAN2 ABCB11 CCDC93 ZNF292	1.95e-03	702	95	8	C0009402
Disease	bone density, lean body mass	TOM1L2 CPED1	2.07e-03	21	95	2	EFO_0003923, EFO_0004995
Disease	blood zinc measurement	SYN3 TRIM45	2.48e-03	23	95	2	EFO_0007584
Disease	Charcot-Marie-Tooth disease (implicated_via_orthology)	GDAP1 MFN2	2.70e-03	24	95	2	DOID:10595 (implicated_via_orthology)
Disease	Attention deficit hyperactivity disorder	PTPRD ZNF292	2.70e-03	24	95	2	C1263846
Disease	hippocampal volume	GDAP1 PTPRD ABCB11 PAM PRKCA	2.77e-03	297	95	5	EFO_0005035
Disease	Uterine leiomyoma	NUP107 KMT5A DNAH2	3.20e-03	91	95	3	HP_0000131

Protein segments in the cluster

Peptide	Gene	Start	Entry
VKDYGEEDLQLRHIK	BEND5	106	Q7L4P6
EKGRLHQLYETKEGE	CCDC186	356	Q7Z3E2
EELNIVKLYAHKGDA	EIF2D	46	P41214
HEIQQKHTREYGKIF	CYP27C1	96	Q4G0S4
ENLIILDTAKKHGYE	CPED1	916	A4D0V7
VKIHVVDEHTGQYVK	AHI1	366	Q8N157
ERKTIIDQHEKEIHY	CCDC65	156	Q8IXS2
KRKGLYVEEKIVEHA	EFL1	1096	Q7Z2Z2
RIQHGEYALEEKVKS	ARHGEF33	46	A8MVX0
VQERYKEQEKEKHHV	C1orf216	156	Q8TAB5
YKLDRIKGEIEFHNV	ABCB11	411	O95342
KLLGEREDVVHVHKY	PAM	396	P19021
ALKRKIAAYDEEIQH	CRACR2A	221	Q9BSW2
VQHRVPEEALKHEKY	CEP170B	101	Q9Y4F5
VVDSGLHKEERYDLK	DHX30	746	Q7L2E3
YLKQKIHDLETELEG	CDK5RAP2	1111	Q96SN8
VVHGKVLQHYQESDK	MTCH2	86	Q9Y6C9
VDEYVKLGHEEQQKR	RCN2	51	Q14257
EDIHHYREQIKRVKD	KRAS	91	P01116
KKRVLEENQEHYHIV	NUP107	501	P57740
EREAILEYILHQKKE	NOSIP	66	Q9Y314
HKEIAQYLLEKGADV	FEM1C	161	Q96JP0
IKDVLRYGEEQLKTH	FCHO1	96	O14526
LDYELGRELVKHLKV	FANCI	281	Q9NVI1
HIKVGETYHQRKEGV	PAN2	871	Q504Q3
YAHQDKRDDVLIGLK	COQ2	251	Q96H96
TEGQKLEYEHLLDVK	KRT28	366	Q7Z3Y7
LVIHAVHEEDRGKYT	MYLK	91	Q15746
HAKEQYRDVIKILLE	LINS1	111	Q8NG48
DILEKLKINEYGQIH	MATN3	471	O15232
YHGDLIEITDAKKRE	KMT5A	286	Q9NQR1
IHKIIDLGYAKELDQ	IKBKB	161	O14920
IEELIKNYDGKVHGD	EZH2	146	Q15910
GLAHAYVKLEVKERD	LRRC23	66	Q53EV4
HLTKKHGRNYIVVDE	MYO18A	1131	Q92614
KYRDTLILHGKVAEE	NEK4	741	P51957
AEGKADAEVKLILYH	GDAP1	16	Q8TB36
IEGLKEELAYLRKNH	KRT16	241	P08779
GQKLEYEQLLDIKVH	KRT27	366	Q7Z3Y8
DILEEIERKLNVYHK	NSMF	386	Q6X4W1
ERKYQHLAKVEEGEA	KIAA1191	61	Q96A73
ERHGYIKGIVKDIIH	RPL8	36	P62917
KHERLVDLHGSVIDY	DSTYK	706	Q6XUX3
VYKNELHRHIEEGLG	MFN2	461	O95140
LYAKIEGRKEHITLD	RELN	496	P78509
VKYLHENGIVHRDLK	CAMK1G	131	Q96NX5
HLKYIKEAVRLDDVA	FRMD6	216	Q96NE9
LYLVHKTDEKGLVRD	DNAH1	316	Q9P2D7
KYKRHQGAEELLDEE	CCDC93	181	Q567U6
YDEIKIELPIHLHQK	DOCK11	711	Q5JSL3
EEKGHEYINNIHLTR	BIRC8	71	Q96P09
HLKENKYLIVVTDGH	COL6A1	146	P12109
DLVKVLYLERSEKGH	CHRDL1	441	Q9BU40
DFIKEYLNGVIHDIK	GLT6D1	241	Q7Z4J2
RKIEEKIIYSKGEEH	CCDC66	346	A2RUB6
DIYEHIKEKLAGLEI	HSD17B3	111	P37058
EIHARDVLEKLYKSG	DNAH2	1716	Q9P225
VKRGKEVIEHYLNEL	SEC14L5	156	O43304
YHSIEKEKTVRHIGD	SLC15A5	16	A6NIM6
SNQEEIRIYGHEIKK	OTOGL	186	Q3ZCN5
ERIKHEKTVDIYGHV	PTPRD	1571	P23468
VKAVHSKDGRDYIIE	SYN3	351	O14994
SEGYIKAIEEHRDKL	TRIM45	281	Q9H8W5
HEGVYRELVDEKALK	TDRD3	186	Q9H7E2
RIYLKAEVADEKLHV	PRKCA	161	P17252
EYALVKGIEKHIIED	MTR	676	Q99707
IDKARSEGLYHEVVK	SMYD1	316	Q8NB12
NYKLIELIHGKDTVE	SETX	1516	Q7Z333
LTVKEVKGHHVRIYE	PKHD1	2911	P08F94
ELDYGKHELVNIRKV	TDRD7	991	Q8NHU6
YHDAKEIFGRIQDKH	SPTBN1	1811	Q01082
EYHEQEEIFKLRLGH	TLK2	401	Q86UE8
KEHLEDIYVGRVLHQ	B3GALT9	201	A8MXE2
EGDREKVLQHEKQVY	AGPS	471	O00116
EIGYILKDNSQKHIE	RNF17	866	Q9BXT8
KLLVKYGADIHQRDE	PPP1R27	81	Q86WC6
KLEEVDRGDVKNYTH	XIRP2	761	A4UGR9
HDGHEEIIKVYLKGR	TUFT1	71	Q9NNX1
LIIHQKIHTGEKRYE	ZFP1	311	Q6P2D0
YKNKLVEHQRIHTGE	ZNF549	596	Q6P9A3
QQLAKLGKEIEEYIH	MTREX	631	P42285
EIHNKTYRHGEKLII	SUSD4	131	Q5VX71
KVYRSQGELEKHLDD	ZNF292	816	O60281
HLAEEYGERAINKVK	WDR44	441	Q5JSH3
AGIKDIDRYHEKLAV	TTC14	191	Q96N46
EVFQLKGGIHKYLEE	TSTD2	376	Q5T7W7
HYEVAELLVKHGAVV	TNKS2	571	Q9H2K2
LNVHKRIHTGEKLYE	ZNF333	521	Q96JL9
QHVRFTEYVKDGLKH	TIMM21	176	Q9BVV7
EKYERHLAEIQGNVK	TSGA10	41	Q9BZW7
RQDLYKHQIDHTGEK	ZNF225	356	Q9UK10
KVLIKERGYEHKNIE	ZNF41	201	P51814
ERGYEHKNIEKIIHV	ZNF41	206	P51814
RLDFYKHQVVHTGEK	ZNF155	356	Q12901
LTEHKLIHTGEKRYE	ZNF117	236	Q03924
ERVGLVKHYLEQHEE	ZNF142	1391	P52746
KGQHEELLREVNKYI	ZNF407	1506	Q9C0G0
GVVHIYEELKRKGVE	TOM1L2	136	Q6ZVM7
IYKIKLDEHIRVHTG	ZNF425	396	Q6IV72
GLHEDLNRVKKKEYV	USP11	411	P51784
LEYIEKLEGKHGSQV	ZNF181	121	Q2M3W8
TLGLYHAQLKVKEEE	GOLGB1	2626	Q14789
KHEKLGEDRIQFLVY	MAPK12	121	P53778
HDKGIIYRDLKLDNV	PRKCH	471	P24723